Search Results 11-20 of 12157 for ������������������������������������������r���:PC53���
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive.
Learn more about the research interests of Lewis R. Roberts, M.B., Ch.B., Ph.D.
Mayo Clinic researcher Pablo R. Castillo, M.D., studies how sleep is affected by nerve stimulation, especially in a part of the brain called the external ...
To evaluate the efficacy and safety of lenalidomide, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R2-CHOP) chemotherapy versus placebo ...
The primary research focus of R. Ross Reichard, M.D., is the neuropathological characterization of the brains of individuals who have been enrolled in large ...
My research involves Cardiac Magnetic Resonance imaging, particularly as it relates to the evaluation of patients with congenital heart disease. PROFESSIONAL ...
Mayo Clinic researcher and cardiologist Hector R. Villarraga, M.D., explores cardiomyopathies, myocardial function and valvular heart diseases as well as ...
Clinical Trials · Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia.
Learn more about the research interests of Caroline (Carli) R. Sussman, Ph.D.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.